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ABSTRACT  
Objectives 
To review existing cardiovascular risk models applicable to South Asian populations.  
Methods 
A systematic review of the literature using a combination of search terms for “South Asian”, 
“cardiovascular”, “risk”/“score” and existing risk models for inclusion. South Asian was 
defined as those residing or with ancestry belonging to the Indian subcontinent. 
Results 
The literature search including MEDLINE and EMBASE identified 7560 papers. After full-
text review, 4 papers met the inclusion criteria.  Only 1 reported formal measures of model 
performance. In that study both a modified Framingham model and QRISK2 showed similar 
good discrimination with AUROCs of 0.73-0.77 with calibration also reasonable in men 
(0.71-0.93) but poor in women (0.43-0.52).   
Conclusion 
Considering the number of South Asians and prevalence of cardiovascular disease, very few 
studies have reported performance of risk scores in South Asian populations. Furthermore, it 
was difficult to make comparisons, as many did not provide measures of discrimination, 
accuracy and calibration. There is a need for further research to evaluate risk models in South 
Asians, and ideally derive and validate cardiovascular risk models within South Asian 
populations. 
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INTRODUCTION 
 Despite advances in diagnosis, treatment and prevention of cardiovascular disease 
(CVD) in recent decades, CVD still remains the single largest cause of non-communicable 
disease death worldwide (WHO 2014). Individuals who are of South Asian descent make up 
one in five of the world’s population and are at particular risk of CVD (Turin et al. 2013).  
Compared to Caucasian populations, South Asians have an increased prevalence of 
established risk factors, such as hyperlipidaemia, smoking and limited physical activity, at 
younger ages (Joshi et al. 2007; Misra and Khurana 2011; Prasad et al. 2011); are younger on 
admission with ischaemic stroke and have poorer 30-day survival (Gunarathne et al. 2008); 
have an increased risk of 30-day mortality from re-infarction or heart failure; and those with 
type-2 diabetes mellitus are affected by cardiovascular events 7.4 years before their 
Caucasian counterparts  (Bellary et al. 2010). 
 The incidence and prevalence of CVD are also continuing to increase in South Asian 
populations. Over the last twenty years, the prevalence of coronary heart disease has 
increased twice-fold in India alone (Turin et al. 2013) and the associated global CVD adult 
burden in developing countries and increasing costs of hospitalisation on local workforces 
(Srivastava and Mohanty 2013) is reason for concern (Prasad et al. 2011). 
  Attempts to reduce this excess morbidity and mortality include collective approaches 
targeting the wider underlying risk factors in an attempt to shift the entire population 
distribution of CVD risk, and approaches that focus on identification of individuals at high 
risk. A key part of the latter approach is the use of risk models that enable estimation of an 
individual’s risk of developing CVD.  These have the potential to help clinicians with 
decisions regarding treatment, facilitate an informed discussion between clinician and patient, 
and may also motivate individuals to improve their health-related behaviours. They also 
provide an opportunity to prioritise individuals with the highest CVD risk and so allocate 
resources more efficiently.  
 A number of risk models capable of identifying those at high risk of CVD exist, 
however most have been developed in Caucasian populations and, given the role of 
population ethnicity and region in modifying cardiovascular risk (Beswick and Brindle 2006) 
it is not clear which is currently the most appropriate for people of South Asian descent. The 
aim of this research was to systematically review and compare existing cardiovascular risk 
models validated in adult South Asian populations to inform the choice of risk model in these 
populations.  
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METHODS 
Search strategy 
 An electronic literature search of MEDLINE, EMBASE (Excerpta Medica dataBASE), 
HMIC (Health Management Information Consortium), AMED (Allied and Complementary 
Medicine Database) and PsychINFO from January 2000 to April 2014 was performed using a 
combination of medical subject heading (MESH) terms and free text incorporating “South 
Asian”, “cardiovascular”, “risk”/“score” and specific risk models for inclusion (see Appendix 
1 for complete search strategy). The search was restricted to human studies. Duplicates were 
removed and the references of each included paper were screened manually for additional 
studies. 
 
Study selection 
Studies were included if they fulfilled all of the following criteria: (i) a primary 
research paper published in a peer-reviewed journal; (ii) contain details of a cardiovascular 
risk model; (iii) apply a cardiovascular risk model to one or more subgroups of a South Asian 
population where South Asian is defined as originating from the Indian subcontinent - India, 
Pakistan, Bangladesh, Nepal, Bhutan, Sri Lanka; (iv) include persons greater than and 
including the age of 18; (v) include a defined endpoint such as 5-year all-cause mortality or 
overall lifetime cardiovascular risk. Studies focussing on sole ethnic groups that did not fall 
under the bracket of “South Asian” and studies with participants with a history of CVD or 
using cardiovascular risks models to estimate disease prevalence or incidence were excluded. 
Abstracts presented at conferences were also excluded.  
One reviewer (DG) performed the search and screened the articles to exclude those 
that were clearly not relevant to assessment of cardiovascular risk at title and abstract level 
whilst a second reviewer (JUS) independently assessed 5% of articles excluded at this stage. 
Both reviewers independently examined all full texts where an article could not be rejected 
purely at title and abstract level. Those articles that did not fulfil inclusion criteria by both 
reviewers were excluded. Any discrepancies around whether articles fulfilled inclusion 
criteria were discussed at consensus meetings.  
 
Data extraction and synthesis 
Data were extracted independently by both researchers using a standardised form to 
decrease recording bias. The form included details on: (i) the risk model itself, including 
availability on the internet and risk model variables included; (ii) model development, 
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including study location, study years, study design, model development method, variables 
included in the model and model performance in the study population such as discrimination, 
calibration, accuracy where applicable; (iii) external validation of the model on a study 
population, including study location, study years, study design,  variables included in the 
model and model performance in the study population such as discrimination, calibration, 
accuracy where applicable.  
 
RESULTS 
After removing duplicate records, the search isolated 7560 articles. 7486 were 
excluded at title and abstract level with a further 70 records excluded after full text 
assessment (Figure 1). Full concordance was reached between researchers during screening 
and a large proportion of articles were excluded because they had used risk scores only to 
estimate prevalence or incidence of CVD or were conference abstracts. A small number were 
also excluded because they were specific to patients with thyroid carcinoma or renal 
transplantation and so not applicable to the general population, the model was used to predict 
in-hospital mortality or the article was not available online or from the British Library. 
Further reference list searching and wider reading did not identify any extra papers that 
warranted inclusion in addition to the wider search results. Only 4 papers (Guha et al. 2004; 
Jaquet et al. 2008; Bellary et al. 2010; Tillin et al. 2014) fulfilled the inclusion criteria. 
Details of the design and methods of these 4 studies are shown in Table 1. Two are based in 
the UK, one in Guadeloupe and one in India. Two included only patients with diabetes 
(Bellary et al. 2010; Jaquet et al. 2008) and all used different outcome measures: Guha et al 
included only acute coronary syndrome whilst Tillin et al included angina, stroke and TIA in 
addition to myocardial infection and coronary heart disease and Bellary et al and Jaquet et al 
included all fatal and non-fatal cardiovascular events. Whilst the aim in all 4 was to assess the 
performance of CVD risk models in South Asian populations, the design of the studies also 
differed with Guha et al using a case-control design with patients recruited in secondary care 
and the other three using a cohort design with follow-up of between 2 to 10 years.     
Between them, the 4 studies included details on the performance of 4 cardiovascular 
risk models in adult South Asian populations. These are summarised in Table 2  along with 
the main results from each study. They  include the Framingham model developed from 
5,573 participants in the USA between 1968-1975 (Anderson et al. 1991), a modified version 
of the Framingham model(NICE 2008), the UKPDS developed in the UK between 1977-
1991 in patients with known type 2 diabetes (Stevens et al. 2001) and QRISK2 developed 
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from the electronic primary health care records of 2,290,000 patients registered with GPs in 
the UK (Hippisley-Cox et al. 2008). All 4 include a set of 4 common risk factors (age, 
gender, smoking history, systolic blood pressure). The Framingham model includes an 
additional 5 risk factors (diastolic blood pressure, total cholesterol, HDL cholesterol, left 
ventricular hypertrophy, diabetes), the UKPDS an additional 3 (total: HDL cholesterol ratio, 
HbA1C and ethnicity) and, QRISK2 11 extra factors, including both variables related to 
biological disease development and others, such as social deprivation, that may be markers of 
other determinants of disease in general  (total: HDL cholesterol ratio, anti-hypertensive use, 
essential hypertension, chronic kidney disease, body mass index, social deprivation, family 
history of ischaemic heart disease in first-degree relative aged below 60 years, ethnicity, type 
2 diabetes, rheumatoid arthritis, and atrial fibrillation). In total, 20 different factors were used 
across the 4 different risk models with the UKPDS using 7 factors and the modified 
Framingham and Framingham 10-year models were composed of 9 components, whilst the 
QRISK2 was made up using 15 factors. All are available online with the exception of the 
modified Framingham risk model which requires multiplication of the online Framingham 
score by a factor of 1.4 for men.  
The Framingham 10-year risk model was used in 3 papers (Guha et al. 2004; Jaquet et 
al. 2008; Bellary et al. 2010).  Guha et al. (2004) used a case-control design to compare the 
10-year Framingham risk model in patients presenting with acute coronary syndrome (ACS) 
and controls with no history of CVD and a normal ECG. They then divided both cases and 
controls into those with and without diabetes and based on the calculated 10-year risk, 
grouped them into high risk (>20%), moderately high risk (10-20%) and low risk (<10%).  
They found a statistically significant difference in the mean projected risk between cases and 
controls without diabetes (mean 10-year risk 14.15 for cases and 8.61 for controls, p<0.01), 
but no difference amongst those with diabetes (mean 10-year risk 11.37 for cases and 10.41 
for controls, p=NS) and, although the distribution of risk was higher in those who developed 
ACS, use of the Framingham 10-year risk score prior to developing ACS would have 
underestimated CVD risk:  only 20% of those without diabetes and 14% of those with 
diabetes would have been identified as high risk and 41% and 53% would have been 
classified as low risk respectively.  
Jaquet et al. (2008) used data from a Guadeloupian retrospective cohort study to 
compare the Framingham 10-year risk model and metabolic syndrome as potential predictors 
of fatal or non-fatal coronary heart disease, ischaemic or haemorrhagic stroke or peripheral 
vascular disease in 148 Indian patients with impaired glucose tolerance or type-2 diabetes. 
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Using Cox proportional hazards modelling they found that higher Framingham risk scores at 
baseline were associated with cardiovascular events at 9 year follow-up but this effect was 
greater for scores ≥ 10% than ≥ 20% (hazard ratio 4.78 (95% CI 1.65-13.5) for a risk score ≥ 
10%, and 2.94 (95% CI 1.42-6.06) for a risk score ≥ 20%).  
The third study to use the Framingham risk model was Bellary et al. (2010) who used 
data from the United Kingdom Asian Diabetes Study (UKADS) cohort (Bellary et al. 2008) 
to compare the Framingham 10-year risk and UKPDS 10-year risk in 1140 British South 
Asians and 317 Caucasians with established type-2 diabetes over a 2-year period. For both 
Framingham and UKPDS risk models, they observed a trend for increased CVD events with 
increasing risk score in the South Asian group. However, despite similar predicted CVD risk 
in the South Asian and Caucasian groups (Framingham 10-year females: 7.3 vs 6.5, males: 
11.7 vs 11.7; UKPDS 10-year females: 10.8 vs 10.1, males 21.9 vs 22.6), over the 2 year 
period there were substantially more cardiovascular events in the South Asian group (26.10 
per 1000 person-years for South Asians versus 19.29 for Caucasians) suggesting that both 
models underestimated risk in the South Asian group.  
The fourth study by Tillin et al. (2014) compared the performance of a modified 
Framingham 10-year model (derived by multiplying the Framingham risk by 1.4 for South 
Asian men and recommended by the NICE guidelines in 2008 (NICE 2008)) and QRISK2 
10-year score in a tri-ethnic cohort including 1317 South Asians with 10-year CVD event 
follow-up.  They chose the same end points as for QRISK2 (first myocardial infarction, 
angina, CHD, stroke, transient ischaemic attack) for assessment of both QRISK2 and the 
modified Framingham 10-year model which was initially developed with only CHD as an 
end-point which would be expected to favour performance of the QRISK2. They also did not 
have data on presence or absence of rheumatoid arthritis, chronic kidney disease or atrial 
fibrillation at baseline and only had data on family history of CHD for survivors at 20 year 
follow-up and left ventricular hypertrophy in a subset and so assumed null values for these 
variables when calculating the risk scores. Despite these limitations it is the only study to 
provide statistical measures of model performance. For South Asians, there was little 
difference in the discriminative performance of the two models with both having moderate 
discrimination and better in females than males: the modified Framingham model had an 
area-under-receiver-operator-curve (AUROC) of 0.73 for males and 0.77 for females and 
QRISK2 an AUROC of 0.73 for males, 0.75 for females; and the R
2
-statistic was also similar 
for the modified Framingham score (males 26.6%, females 37.6%) and QRISK2 model 
(males 26.3%, females 36.4%). Both under-predicted risk with the modified Framingham 
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model better calibrated in men compared to the QRISK2 (predicted: observed (95% CI) 
modified Framingham 0.93 (0.88-0.96) vs QRISK2 0.71 (0.64-0.78)) and QRISK 2 better in 
women (predicted: observed QRISK2 0.52 (0.32-0.72) vs modified Framingham 0.43 (0.25-
0.63)). Overall performance, as measured by the Brier M statistic, was moderate and almost 
identical for both models with values of 0.14 and 0.10 for South Asian males and females 
respectively. 
 
DISCUSSION 
Despite the increasing use of cardiovascular risk models and recognition of the impact 
of ethnicity on CVD risk, this systematic review identified only 4 studies that assessed the 
performance of risk models in South Asian populations.  All showed that an increased risk 
score was associated with increased CVD events, and 3 of the 4 risk models underestimated 
risk in South Asian populations. Only 1 reported formal measures of model performance. In 
that study (Tillin et al. 2014) both a modified Framingham model and QRISK2 showed 
similar good discrimination with AUROCs of 0.73-0.77 with calibration also reasonable in 
men (0.71-0.93) but poor in women (0.43-0.52). 
 
Strengths and Limitations 
The main strength of this study is the systematic approach and use of different search 
engines including EMBASE and MEDLINE as well as manual screening of the reference 
lists of included articles. However, there is an element of publication bias that is intrinsic to 
the literature limiting available analysable data sets so we cannot exclude the possibility that 
there are other studies that we did not identify. 
The main weaknesses relate to the volume and quality of the published data.  The 
results of the widespread search found only 4 studies using 4 risk models. All used different 
outcome measures, only 1 reported statistical measures for performance, and only the 
Framingham model was assessed in more than one study so the conclusions that can be 
drawn from the extracted data are limited. Additionally the populations included in the 
studies are of limited generalisability: two included only participants with type 2 diabetes and 
1 only those presenting to one secondary care hospital. Although unlikely to have a large 
effect, the only study to include performance measures (Tillin et al. 2014) also had missing 
data for several of the component risk factors for each model.  Furthermore, of the studies 
included, only 2 specified the subgroups of South Asians within their study (Jaquet et al. 
2008; Tillin et al. 2014) whilst the other 2 described the included population as only ‘South 
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Asian’ (Bellary et al. 2010) or ‘Indian’ (Guha et al. 2004). This makes interpreting and 
applying the results to specific sub-groups more difficult. Finally, there was a lack of 
reporting of consistent measures of discrimination, calibration and accuracy making a 
comparison between risk models difficult.  
 
Implications for clinicians and policy makers 
Despite these limitations, the findings from this review are of relevance to the large 
number of clinicians worldwide that use CVD risk information with South Asian patients 
regularly in their practice, and policy makers involved in designing and implementing 
strategies for the prevention of CVD.  Given the widespread use of CVD risk models and the 
increasing South Asian population (UN 2014), it is surprising and concerning that there is 
such limited data on the performance of these models in South Asian populations.  Only 4 
risk models have been tested and performance data is only available for 2.  Increased risk 
scores in all 4 models are associated with increased CVD events, but, where reported, all 
underestimate risk.  This underestimation is perhaps not surprising for the Framingham risk 
model as it was developed in a cohort of white Caucasian individuals from the late 1960’s 
onwards (Anderson et al. 1991) and, along with other risk models, is commonly believed to 
underestimate CVD risk when applied to 1990’s and 2000’s South Asian populations 
(Kanjilal et al. 2008; Bansal et al. 2009; Perumal et al. 2012; Khanna et al. 2013) and when 
compared to expected mortality rates amongst South Asians (Cappuccio et al. 2002; Quirke 
et al. 2003; Aarabi and Jackson 2005; Bhopal et al. 2005; Brindle et al. 2006; Wells et al. 
2007; Kumar et al. 2009; Perumal et al. 2012). QRISK2, however, was derived using a large 
South Asian population (n=17,102) (Hippisley-Cox et al. 2008) and so would be expected to 
take account of differences in intrinsic CVD risk amongst South Asians. Nevertheless, the 
performance of QRISK2 and the modified Framingham model in South Asian populations 
are not dissimilar from those in white Caucasians or other ethnic groups: in the study by 
Tillin et al. (2014) the AUROC and R
2
 statistic for both risk models was higher in South 
Asians than Europeans or African Caribbeans or all ethnicities combined for both men and 
women.  The notable difference is in South Asian females where both QRISK2 and the 
modified Framingham model underestimate risk substantially more than for other ethnic 
groups (predicted: observed 0.52 (95% CI 0.34-0.72) for QRISK2 and 0.43 (95% CI 0.25-
0.63) for modified Framingham compared to 0.73 (0.57-0.88) and 0.74 (0.57-0.88) 
respectively in Europeans), and the QRISK2 high risk classification would miss 
approximately two thirds of events. This may be explained by the absence of any incident 
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cases in South Asian women in the Framingham model development population (compared 
to 241 in white Caucasian women) and the small number of incident cases in South Asian 
women in the QRISK2 derivation dataset relative to those in the White ethnic group (413 
compared to 40,278).  This underestimation is important though for clinicians to recognise as 
women often do not present with typical symptoms before or during a cardiovascular event 
(McSweeney et al. 2003; McSweeney et al. 2010) and alternative strategies may be required 
to identify high risk South Asian women. 
When choosing which model to use clinicians should be aware that both QRISK2 and 
a modified Framingham model have been externally tested in South Asian populations and 
both have similar modest discrimination and overall performance but under-estimate risk, 
particularly in South Asian women. The choice of which to use can therefore be guided by 
access, availability of risk factors and local preferences. Both QRISK2 and the Framingham 
model are freely accessible on the internet but, whilst QRISK2 includes an option for ‘South 
Asian’, when using the Framingham model in South Asians clinicians would need to multiply 
the calculated risk by 1.4 for men before interpreting it. This is not difficult but adds a further 
step into risk calculation and limits the use of the Framingham model to screen electronic 
records. QRISK2 includes 15 variables compared to the 9 in the Framingham score.  Age, 
gender, systolic BP, total cholesterol, HDL, smoking status and diabetes are risk factors 
common to both scores with the Framingham model additionally including left ventricular 
hypertrophy and QRISK2 body mass index, family history, social deprivation, 
antihypertensive treatment, ethnicity, hypertension, rheumatoid arthritis, chronic kidney 
disease and atrial fibrillation.  Some of these additional variables in the QRISK2 model may 
not be readily known, however, in the validation study (Tillin et al. 2014), data was also not 
available for rheumatoid arthritis, chronic kidney disease, atrial fibrillation or left ventricular 
hypertrophy and family history data was missing for many participants so this may have 
limited consequences. Both are also recommended in current guidelines but these differ 
between countries with the UK National Institute for Health and Clinical Excellence (NICE) 
currently recommending QRISK2 (NICE 2015) and the American College of Cardiology 
suggesting the Framingham risk model or SCORE guidelines (Conroy et al. 2003) based on 
validation in Afro-Caribbeans (Goff et al. 2014).  
 
Unanswered questions and future research 
Whilst this review provides a summary of published studies reporting the 
performance of CVD risk models in South Asian populations, it also highlights the lack of 
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evidence in this area. Given the increasing incidence of CVD and reliance on risk prediction 
tools for treatment decisions, there is the need for further research in this area.  This includes 
both wider validation of existing risk models, such as ETHRISK which is another modified 
version of the Framingham risk model designed to take account of ethnicity (Brindle et al. 
2006), and the development of new models incorporating ethnicity to reduce the intrinsic 
difficulties when applying a risk model developed in one ethnicity to a different ethnicity in a 
different location and point in time. This work will also need to address the difficulties 
involved in developing risk models for South Asians where the umbrella term ‘South Asian’ 
includes persons with different levels of acculturation, different migration patterns and 
different ethnic subgroups, both within and outside the Indian subcontinent. 
In the past this has been limited by the lack of studies including South Asian 
populations but with the development of large cohorts such as the Emerging Risk Factors 
Collaboration (Danesh et al. 2007; Thompson et al. 2010) and UK Biobank (Elliott and 
Peakman 2008; Kaptoge et al. 2012) and the increasing availability of electronic medical 
record databases, it should now be possible to validate existing models and develop new 
ones. Only once we have an accurate risk model for South Asian populations, will we be able 
to maximise the potential benefits of a calibrated CVD risk assessment and directed 
secondary preventive strategies for this group who make up 1 in 5 of the ever-expanding 
world population.  
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Table 1: Summary of external validation studies published in English between January 2000 and April 2014. CVD – cardiovascular disease, GP – 
general practice, CHD – coronary heart disease, NICE – National Institute for Health and Clinical Excellence, TIA – transient ischaemic attack, ACS – 
acute coronary syndrome, STEMI – ST Elevation Myocardial Infarction, NSTEMI – Non-ST Elevation Myocardial Infarction, M – males, F – females. 
 
 
Author 
and 
date 
Risk scores 
applied 
Country 
Period 
of 
study 
Study design 
Data collection 
method 
Outcome 
Definition of 
South Asian 
Study population Exclusion criteria 
Total 
n 
Number 
of South 
Asian 
cases 
Gender of 
South 
Asian 
cases 
(male, %) 
Age of 
South 
Asian 
cases 
Bellary, 
2010 
Framingham 
10-year & 
UKPDS 10-
year 
Coventry & 
Birmingham, 
England 
2004 - 
2007 
Prospective 
cohort (2 year 
follow up) 
Examination and 
blood tests for 
baseline risk; CVD 
events and mortality 
extracted from GP 
records and cause of 
death from 
GP/hospital records or 
register of births and 
deaths 
Fatal and non-fatal 
cardiovascular 
events 
South Asian 
Aged 30-74 with type 
2 diabetes from UK 
Asian Diabetes Study 
records (South Asians) 
and  21 GP Practices 
(white European). 
Type 1 diabetes 
mellitus, impaired 
fasting glucose, 
impaired glucose 
tolerance, Ages < 
30, Ages > 74, No 
previous history of 
CVD including 
CHD, stroke, 
peripheral vascular 
disease 
1978 1486 
Unknown. 
52.2 (for 
entire 
cohort) 
57.0 ± 
11.9 
(for 
entire 
cohort) 
Jaquet, 
2008 
Framingham 
10-year 
St. Francois, 
Guadeloupe 
1997 - 
2006 
Longitudinal, 
retrospective 
cohort (9 year 
follow-up)  
Questionnaire/intervie
w and investigation 
and hospital records 
for baseline risk; 
hospital medical 
records and 
questionnaires for 
outcome 
Fatal and non-fatal 
cardiovascular 
events requiring 
hospitalisation - 
coronary heart 
disease, 
ischaemic/haemorr
hagic stroke, 
peripheral vascular 
disease. 
Indian   
Indian (by family 
name, self-stated or 
physical appearance) 
withimpaired glucose 
tolerance or type 2 
diabetes mellitus. 
None specified 148 148 43.9 
M 57.3 
± 11.3, 
F 52.0 
± 12.7 
Tillin, 
2014 
Modified 
Framingham 
10-year [x 1.4 
for 
men](NICE 
2008)  and 
QRISK2 10-
year 
West London, 
UK 
1988 -
2011 
Cohort study 
(10 year 
follow up) 
Baseline 
questionnaire, 
examination and 
investigation.  
Outcome from official 
cause of death, 
primary care records, 
patient report, hospital 
episode statistics or 
physician report 
First myocardial 
infarction, angina, 
CHD, stroke, TIA 
South Asian - 
Indian, 
Pakistani 
Aged 40–69 years at 
baseline (1988–1991) 
randomly selected 
from primary care 
physician lists and 
workplaces 
Previous CVD 3674 1317 81.7 
Males  
50.8 ± 
6.9; 
Female
s 50.3 
± 6.5 
Guha, 
2004 
Framingham 
10-year 
India 
Not 
given 
Case control Medical records 
Acute coronary 
syndrome 
Not given 
specifically 
but in India 
Patients presenting 
with ACS: STEMI, 
non-STEMI and 
unstable angina with 
troponinaemia 
Not specified 464 464 78.6 57.6 
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Table 2: Summary of cardiovascular risk models that have been externally validated in South Asian populations in studies published in English 
between January 2000 and April 2014  BP – blood pressure; HDL – high density lipoprotein, TC – total cholesterol, CHD – coronary heart disease, 
CVD – cardiovascular disease, ACS – acute coronary syndrome, BMI – body mass index, CKD – chronic kidney disease, AF – atrial fibrillation, AUROC 
– area under receiver operator curve, HR – hazard ratio, M – males, F – females. 
Risk model External validation 
Risk model Factors included in model Outcome Country 
Period of 
follow-up 
n 
Method of 
model 
development 
Author 
and date 
Key findings 
Framingham 
10-year 
 
Age, gender, systolic BP, 
diastolic BP, total 
cholesterol, HDL, cigarette 
smoking, diabetes, left 
ventricular hypertrophy 
 
10-year 
relative risk 
of CHD 
event (± 
stroke and 
CVD event) 
 
USA 1968-1975 
5573 
 
Parametric 
regression 
Bellary et 
al, 2010 
Trend for increased CVD events with increasing predicted risk. 
Despite similar predicted CVD risk in the South Asian and Caucasian 
groups there were 35% more CVD events in the South Asian group 
suggesting that the score underestimated risk in the South Asian 
group. 
Guha et 
al, 2004 
Applying risk model prior to developing ACS would have 
underestimated CVD risk:  only 20% of those without diabetes and 
14% of those with diabetes would have been identified as high risk 
and 41% and 53% of those with ACS would have been classified as 
low risk. 
Jaquet et 
al, 2008 
Predicted risk scores at baseline were associated with CVD events at 
follow-up but this effect was greater for scores ≥ 10% than ≥ 20% 
(HR 4.78 (95% CI 1.65-13.5) for a risk score ≥ 10%, and 2.94 (95% 
CI 1.42-6.06) for a risk score ≥ 20%). 
Modified 
Framingham 
10-year x 1.4 
for men 
(NICE 2008) 
Age, gender, systolic BP, 
diastolic BP, total 
cholesterol, HDL, cigarette 
smoking, diabetes, left 
ventricular hypertrophy 
10-year 
relative risk 
of CHD 
event 
USA 1968-1975 5573 
Parametric 
regression 
Tillin et 
al, 2014 
AUROC M 0.73 (0.69-0.77), F 0.77 (0.69-0.86) 
D-stat M 1.23 (1.00-1.47), F 1.59 (0.96-2.21) 
R2 M 26.6 (19.2-33.9), F 37.6 (18.1-53.9). 
Ratio of predicted to observed M 0.93 (0.88-0.96), F 0.43 (0.25-0.63)  
Brier M 0.14 (0.12-0.15), F 0.10 (0.073-0.13) 
QRISK2 10-
year 
Age, gender, systolic BP, 
smoking status, TC⁄HDL 
ratio and presence of type 2 
diabetes, BMI, family 
history, social deprivation, 
antihypertensive treatment, 
self-assigned ethnicity, 
hypertension, rheumatoid 
arthritis, CKD and AF 
10-year risk 
of 
cardiovascul
ar disease 
(no further 
description 
offered) 
UK 1993-2008 2,290,000 
Cox-
regression 
Tillin et 
al, 2014 
AUROC M 0.73 (0.69-0.77), F 0.75 (0.66-0.84) 
D-stat M 1.22 (0.99-1.45), F 1.55 (0.91-2.19) 
R2 M 26.3 (19.0-33.5), F 36.4 (16.6-53.3). 
Ratio of predicted to observed M 0.71 (0.64-0.78), F 0.52 (0.34-0.72)  
Brier M 0.14 (0.12-0.15), F 0.10 (0.063-0.14) 
UKPDS 10-
year 
Age, gender, ethnicity, 
systolic BP, total 
cholesterol/HDL ratio, 
HbA1C, cigarette smoking 
10-year 
absolute risk 
of CHD 
event 
UK 1977-1991 4540 
Parametric 
risk modelling 
Bellary et 
al, 2010 
Trend for increased CVD events with increasing predicted risk. 
Despite similar predicted CVD risk in the South Asian and Caucasian 
groups there were 35%  more CVD events in the South Asian group 
suggesting that the score underestimated risk in the South Asian 
group. 
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Figure 1. PRISMA diagram for Cardiovascular Risk Scores for South Asian populations: a systematic 
review with studies published in English between January 2000 and April 2014. EMBASE – Excerpta 
Medica dataBASE; HMIC – Health Management Information Consortium; AMED – Allied and 
Complementary Medicine Database 
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